Over 130 years of experience in Pharmaceutical Research and Development

 Experience gained in a wide range of international companies


Joel Vacus
Ph.D. • CEO and CSO
Prior to setting up Drugabilis in 2004, Dr. Joel Vacus held various positions at Rhône-Poulenc Rorer, Parke-Davis and Pfizer during the first 12 years of his career. His roles within Pfizer included Head of Pharmaceutical Sciences, Member of the Research Leadership Team and Member of the Site Leadership Team at the Fresnes site (France), where he had earlier been appointed as Scientific Advisor to the Pharmaceutical Sciences Department.

For five years, Dr. Joel Vacus built and led “Pharm Sci Discovery Support” at Parke-Davis Fresnes, and later on at Pfizer, aiming to improve new drug candidate selection through earlier assessment of research compounds’ drug-like properties. He had previously worked for five years in preclinical development at Rhône-Poulenc Rorer where he and his team dealt more specifically with early formulations used for animal testing and with physico-chemical characterisation of new chemical entities.

Since then, Dr. Joel Vacus has also acquired strong experience in new drug delivery systems, including micellar systems, liposomes, nanoparticles, self-emulsifying systems and non-viral vectors for gene therapy. He is the author of several patents and publications in these fields. He has a chemistry and physico-chemistry background (graduated from ESPCI - Paris) and has a Ph.D. in inorganic chemistry.

Joel Vacus coordinates most of the trouble-shooting studies and a large number of client projects outsourced to Drugabilis. He also works as strategic and scientific consultant to some of Drugabilis’ regular customers.